Literature DB >> 15351863

Extrinsic coagulation pathway activation and metalloproteinase-2/TIMPs system are related to oxidative stress and atherosclerosis in hemodialysis patients.

Krystyna Pawlak1, Dariusz Pawlak, Michal Mysliwiec.   

Abstract

Matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs), together with extrinsic coagulation pathway activation and increased oxidative stress (SOX) have all been implicated as important factors in atherosclerosis and vascular remodelling. The aim of the present study was to investigate whether the MMPs/TIMPs system is associated with activation of the extrinsic coagulation pathway in conditions of increased SOX in hemodialysis (HD) patients. In HD patients, with and without cardiovascular disease (CVD), and in controls, we compared pre-dialysis levels of MMP-2, MMP-9,TIMP-1,TIMP-2; the markers of extrinsic coagulation pathway-tissue factor (TF) and its inhibitor (TFPI), prothrombin fragment F1+2 (F1+2); a marker of SOX-Cu/Zn superoxide dismutase (Cu/Zn SOD) and a surrogate of atherosclerotic disease-intima media thickness (IMT). Hemodialysis patients, particularly those with CVD, showed a significant increase in values of MMP-2/TIMPs, markers of the extrinsic coagulation pathway, Cu/Zn SOD and IMT as compared to controls. The markers of coagulation activation positively correlated with the MMP-2/TIMPs system, whereas they did not correlate with MMP-9. In addition, both MMP-2/TIMPs as well as extrinsic coagulation parameters were related to the prevalence of increased SOX, IMT and CVD. Multiple stepwise regression analysis showed that low TIMP-2 followed by increased Cu/Zn SOD and MMP-2 levels independently and significantly predicted elevated IMT on maintenance HD patients. In conclusion, our data suggest that the MMP-2/TIMPs system and an activated extrinsic coagulation pathway could cooperate in conditions of elevated SOX and could influence arterial remodeling resulting in the presence of CVD in haemodialysis patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15351863     DOI: 10.1160/TH04-02-0128

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Atheroprotective role of interleukin-6 in diet- and/or pathogen-associated atherosclerosis using an ApoE heterozygote murine model.

Authors:  Monika Madan; Biswadev Bishayi; Michael Hoge; Salomon Amar
Journal:  Atherosclerosis       Date:  2007-04-06       Impact factor: 5.162

2.  The serum levels of MMP-9, MMP-2 and vWF in patients with low doses of urokinase peritoneal dialysis decreased uremia complicated with cerebral infarction.

Authors:  Shu-Jin Wang; Zhong-Sen Qu; Qing-De Zhang; Liang Li; Feng Wang; Bin Zhang; Bang-Li Wu; Yu-Wu Zhao
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 3.  The Association of Matrix Metalloproteinases with Chronic Kidney Disease and Peripheral Vascular Disease: A Light at the End of the Tunnel?

Authors:  Michele Provenzano; Michele Andreucci; Carlo Garofalo; Teresa Faga; Ashour Michael; Nicola Ielapi; Raffaele Grande; Paolo Sapienza; Stefano de Franciscis; Pasquale Mastroroberto; Raffaele Serra
Journal:  Biomolecules       Date:  2020-01-17

Review 4.  Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review.

Authors:  Andreas Kousios; Panayiotis Kouis; Andrie G Panayiotou
Journal:  Int J Nephrol       Date:  2016-03-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.